Prognostic implications of and clinical risk factors for acute lung injury and organizing pneumonia after lung transplantation: Data from a multicenter prospective cohort study.


Journal

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
ISSN: 1600-6143
Titre abrégé: Am J Transplant
Pays: United States
ID NLM: 100968638

Informations de publication

Date de publication:
12 2022
Historique:
revised: 05 08 2022
received: 17 02 2022
accepted: 21 08 2022
pubmed: 30 8 2022
medline: 6 12 2022
entrez: 29 8 2022
Statut: ppublish

Résumé

We determined prognostic implications of acute lung injury (ALI) and organizing pneumonia (OP), including timing relative to transplantation, in a multicenter lung recipient cohort. We sought to understand clinical risks that contribute to development of ALI/OP. We analyzed prospective, histologic diagnoses of ALI and OP in 4786 lung biopsies from 803 adult lung recipients. Univariable Cox regression was used to evaluate the impact of early (≤90 days) or late (>90 days) posttransplant ALI or OP on risk for chronic lung allograft dysfunction (CLAD) or death/retransplantation. These analyses demonstrated late ALI/OP conferred a two- to threefold increase in the hazards of CLAD or death/retransplantation; there was no association between early ALI/OP and these outcomes. To determine risk factors for late ALI/OP, we used univariable Cox models considering donor/recipient characteristics and posttransplant events as candidate risks. Grade 3 primary graft dysfunction, higher degree of donor/recipient human leukocyte antigen mismatch, bacterial or viral respiratory infection, and an early ALI/OP event were significantly associated with increased late ALI/OP risk. These data from a contemporary, multicenter cohort underscore the prognostic implications of ALI/OP on lung recipient outcomes, clarify the importance of the timing of these events, and identify clinical risks to target for ALI/OP prevention.

Identifiants

pubmed: 36031951
doi: 10.1111/ajt.17183
pii: S1600-6135(23)00051-5
pmc: PMC9925227
mid: NIHMS1869000
doi:

Types de publication

Multicenter Study Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

3002-3011

Subventions

Organisme : NHLBI NIH HHS
ID : K23 HL138256
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI113315
Pays : United States
Organisme : NIAID NIH HHS
ID : UM2 AI117870
Pays : United States
Organisme : NIH HHS
ID : UM2AI117870
Pays : United States

Informations de copyright

© 2022 The American Society of Transplantation and the American Society of Transplant Surgeons.

Références

Int Stat Rev. 2017 Aug;85(2):185-203
pubmed: 29307954
Am J Respir Crit Care Med. 2004 Nov 1;170(9):1022-6
pubmed: 15297270
Transplant Direct. 2018 Jul 11;4(8):e370
pubmed: 30255130
J Heart Lung Transplant. 2019 May;38(5):493-503
pubmed: 30962148
J Heart Lung Transplant. 2017 Oct;36(10):1097-1103
pubmed: 28942784
J Heart Lung Transplant. 2012 Apr;31(4):354-63
pubmed: 22330935
Am J Transplant. 2016 Apr;16(4):1216-28
pubmed: 26845386
Am J Respir Crit Care Med. 2013 Mar 1;187(5):518-26
pubmed: 23328531
Am J Respir Crit Care Med. 2013 Nov 1;188(9):1117-25
pubmed: 24063316
J Heart Lung Transplant. 2013 Jan;32(1):70-7
pubmed: 23260706
Am J Transplant. 2022 Sep;22(9):2169-2179
pubmed: 35634722
J Heart Lung Transplant. 2007 Oct;26(10):1004-11
pubmed: 17919620
J Heart Lung Transplant. 2019 Oct;38(10):1042-1055
pubmed: 31548030
Am J Respir Crit Care Med. 2013 Jun 15;187(12):1360-8
pubmed: 23614642
J Heart Lung Transplant. 2007 Dec;26(12):1229-42
pubmed: 18096473
J Heart Lung Transplant. 2016 Apr;35(4):397-406
pubmed: 27044531
Eur Respir J. 2020 Sep 3;56(3):
pubmed: 32381491
Am J Transplant. 2005 Aug;5(8):2022-30
pubmed: 15996255
J Heart Lung Transplant. 2002 Nov;21(11):1206-12
pubmed: 12431494
Am J Transplant. 2015 Mar;15(3):792-9
pubmed: 25683785

Auteurs

Elizabeth N Pavlisko (EN)

Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA.

Megan L Neely (ML)

Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA.

Heather Kopetskie (H)

Rho, Durham, North Carolina, USA.

David M Hwang (DM)

Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
University Health Network, University of Toronto, Toronto, Ontario, Canada.

Carol F Farver (CF)

Cleveland Clinic, Cleveland, Ohio, USA.

W Dean Wallace (WD)

University of Southern California, Los Angeles, California, USA.
University of California Los Angeles, Los Angeles, California, USA.

Andrea Arrossi (A)

Cleveland Clinic, Cleveland, Ohio, USA.

Peter Illei (P)

Johns Hopkins University, Baltimore, Maryland, USA.

Michelle L Sever (ML)

Rho, Durham, North Carolina, USA.
PPD Government and Public Health Services, Morrisville, North Carolina, USA.

Jerry Kirchner (J)

Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA.

Courtney W Frankel (CW)

Division of Pulmonary Allergy and Critical Care Medicine, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.

Laurie D Snyder (LD)

Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA.
Division of Pulmonary Allergy and Critical Care Medicine, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.

Tereza Martinu (T)

University Health Network, University of Toronto, Toronto, Ontario, Canada.

Michael Y Shino (MY)

University of California Los Angeles, Los Angeles, California, USA.

Lorenzo Zaffiri (L)

Division of Pulmonary Allergy and Critical Care Medicine, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.

Nikki Williams (N)

National Institute of Allergy and Infectious Diseases, Rockville, Maryland, USA.

Mark A Robien (MA)

National Institute of Allergy and Infectious Diseases, Rockville, Maryland, USA.

Lianne G Singer (LG)

University Health Network, University of Toronto, Toronto, Ontario, Canada.

Marie Budev (M)

Cleveland Clinic, Cleveland, Ohio, USA.

Wayne Tsuang (W)

Cleveland Clinic, Cleveland, Ohio, USA.

Pali D Shah (PD)

Johns Hopkins University, Baltimore, Maryland, USA.

John M Reynolds (JM)

Division of Pulmonary Allergy and Critical Care Medicine, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.

S Sam Weigt (SS)

University of California Los Angeles, Los Angeles, California, USA.

John A Belperio (JA)

University of California Los Angeles, Los Angeles, California, USA.

Scott M Palmer (SM)

Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA.
Division of Pulmonary Allergy and Critical Care Medicine, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.

Jamie L Todd (JL)

Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA.
Division of Pulmonary Allergy and Critical Care Medicine, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH